In this episode of Making Sense with Sam Harris, Ben Lamm of Colossal Biosciences discusses his company's groundbreaking efforts to revive extinct species like the woolly mammoth through advanced genetic engineering tools. Lamm explains Colossal's rigorous approach, which involves analyzing ancient genomes and making precise edits to the DNA of living organisms like the Asian elephant, the mammoth's closest living relative.
Beyond the process and challenges of de-extinction, the conversation explores the broader implications of Colossal's work. Lamm highlights how innovations in genome editing and AI guidance could lead to breakthroughs in human health, anti-aging treatments, conservation efforts, and ecosystem restoration. While the science progresses, ethical debates around "playing God" and ecological impacts remain.
Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Colossal Biosciences, co-founded by Ben Lamm, is a pioneering company leveraging cutting-edge genetic tools like CRISPR and AI to revive extinct species like the woolly mammoth, Tasmanian tiger, and dodo.
Rather than the fictional "Jurassic Park" approach of combining incomplete DNA fragments from different species, Colossal takes a comprehensive approach:
Even as the science progresses, de-extinction efforts face significant challenges:
Lamm highlights how Colossal's de-extinction work drives innovations applicable to human health and conservation:
1-Page Summary
Colossal Biosciences, co-founded by Ben Lamm, is at the forefront of leveraging advanced genetic engineering techniques like CRISPR and AI to reverse the extinction of species such as the woolly mammoth, Tasmanian tiger, and dodo.
Taking a comprehensive and scientific approach to de-extinction, Colossal Biosciences focuses on a deep understanding of the genomes of extinct species rather than the traditional fiction-cinema methods of filling genetic gaps with related-species DNA.
Ben Lamm discusses how Colossal's goal is not to fill in genetic gaps with DNA from other species as depicted in "Jurassic Park." Instead, their real-life scientific approach is to fully understand the genomes of extinct species to accurately select and engineer key genes into a living species. He emphasizes the fundamental differences in approach, clarifying that contrary to the "Jurassic Park" method, where ancient DNA is sourced from amber—an unreliable storage medium—Colossal invests in robust genomic analysis using the closest living relatives as a starting point.
The Asian elephant, sharing 99.6% of its genetics with the woolly mammoth, serves as the extant genetic proxy for the mammoth. With over 65 mammoth genomes collected from Siberian and Russian samples spanning approximately 700,000 years, including protein-coding regions from Colombian mammoths and step mammoths, Colossal has a comprehensive genetic catalog to work from. With regards to the Tasmanian tiger, Lamm highlights the near completion of its genome, a remarkable achievement that sets the stage for their de-extinction efforts.
The science and technology behind de-extinction
Resurrecting extinct species, such as the work being done by Colossal, introduces various practical and ethical challenges that require careful consideration.
One of the significant technical hurdles in de-extinction efforts involves reliably culturing and editing the cells of the target species. Techniques such as CRISPR gene editing have revolutionized the field, but ensuring that these cells can develop properly is a complex task. For instance, Colossal has had to learn how to regulate the overexpression of a protein called p53, which is crucial to allowing cell editing without causing either senescence, which is cellular aging, or cancer in animals related to the extinct ones, such as elephants.
Ensuring that the edited cells lead to viable and healthy offspring is another significant challenge. There needs to be a capability to gestate and deliver these offspring, which may require surrogate animals from related species or even artificial wombs. Furthermore, genetic modifications must be done with precision to reduce off-target effects or unintended consequences that could harm the animal or alter its behavior and functionality in unpredictable ways.
Beyond the technical aspects, there are open questions surrounding the ecological and evolutionary impacts of reintroducing extinct megafauna like the woolly mammoth. The reinsertion of such species into modern ecosystems can have wide-reaching effects, including altering plant communities, influencing the behavior of other animals, and potentially disrupting current habitats.
Understanding these potential ecological impacts and risks is critical before moving forward. This includes considering how the reintroduced species would interact with existing wildlife and their habitats and the possible unintended consequences that may arise as a result of their presence in today's ecosystems.
The ethical debates around de-extinction are as robust as the scientific ones. There a ...
The practical and ethical considerations of resurrecting extinct species
Colossal, a company leading the de-extinction initiative, sees its work not just as a means to bring back extinct species but as a catalyst for innovation with far-reaching implications for both human healthcare and environmental conservation.
Ben Lamm, a key figure in Colossal, articulates that the technologies being honed for the de-extinction of lost species could lead to significant advancements in human health. He suggests that the tools employed in de-extinction will find direct applications in healthcare, affirming the potential to create substantial value.
Colossal's research into elephant genetics, specifically the regulation of p53—a gene tied to cancer resistance—may unlock new insights into combating human aging and cancer. By manipulating this gene, Colossal may foster breakthroughs that can be extrapolated to human oncology, providing potential new avenues for treatment.
Though no specific details are provided, Lamm alludes to the possibility of using the company's genetic engineering technology for biodiversity and ecosystem restoration. The tools designed for de-extinction could be repurposed to support broader conservation efforts, thus enhancing global biodiversity.
The potential real-world applications and impacts of this work
Download the Shortform Chrome extension for your browser